Indaptus Therapeutics (INDP) Stock Chart & Stock Price History → HUGE BUY ALERT: Move Fast, Musk... (From Stansberry Research) (Ad) Free INDP Stock Alerts $2.12 -0.03 (-1.40%) (As of 09:49 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Indaptus Therapeutics Stock Price Performance5 Day Performance+2.42%1 Month Performance-23.47%3 Month Performance+26.19%6 Month Performance-6.61%Year-To-Date Performance+20.45%1 Year Performance+0.47% Receive INDP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyGuard Against the Coming Financial UpheavalAmerica’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.You can stream it for free right here. INDP Stock Chart for Tuesday, May, 14, 2024 INDP Chart by TradingView Indaptus Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$2.15$2.12-1.40%$2.23$2.122,416 shs$18.11 million05/10/2024$2.07$2.15+3.86%$2.19$2.115,460 shs$18.36 million05/09/2024$2.08$2.07-0.48%$2.11$2.063,555 shs$17.68 million05/08/2024$2.05$2.08+1.46%$2.09$2.055,627 shs$17.76 million05/07/2024$2.03$2.05+0.99%$2.12$2.033,659 shs$17.51 million05/06/2024$2.02$2.03+0.50%$2.12$2.006,987 shs$17.33 million Get the Latest News and Ratings for INDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$2.01$2.02+0.50%$2.11$2.002,890 shs$17.25 million05/02/2024$2.02$2.01-0.50%$2.16$1.9811,715 shs$17.17 million05/01/2024$2.17$2.02-6.91%$2.28$2.0021,266 shs$18.53 million04/30/2024$2.12$2.17+2.27%$2.23$2.144,784 shs$18.53 million04/29/2024$2.11$2.12+0.56%$2.25$2.067,640 shs$18.12 million04/26/2024$2.18$2.11-3.21%$2.22$2.058,075 shs$18.02 million04/25/2024$2.35$2.18-7.23%$2.32$2.1529,128 shs$18.62 million04/24/2024$2.49$2.35-5.62%$2.67$2.2649,609 shs$20.07 million04/23/2024$2.44$2.49+2.05%$2.68$2.477,352 shs$21.27 million04/22/2024$2.36$2.44+3.39%$2.47$2.364,186 shs$20.84 million04/19/2024$2.52$2.36-6.35%$2.56$2.3410,557 shs$20.15 million04/18/2024$2.66$2.52-5.26%$2.63$2.4527,003 shs$21.52 million04/17/2024$2.73$2.66-2.56%$2.74$2.3525,070 shs$22.72 million04/16/2024$2.65$2.73+3.02%$2.79$2.697,407 shs$23.31 million04/15/2024$2.77$2.65-4.33%$2.95$2.5255,048 shs$22.63 million04/12/2024$2.75$2.77+0.73%$2.87$2.7153,745 shs$23.66 million04/11/2024$2.44$2.75+12.70%$2.75$2.4592,478 shs$23.49 million04/10/2024$2.46$2.44-0.81%$2.54$2.3120,114 shs$20.84 million04/09/2024$2.38$2.46+3.36%$2.46$2.3210,325 shs$21.01 million04/08/2024$2.44$2.38-2.46%$2.47$2.3113,250 shs$20.32 million04/05/2024$2.25$2.42+7.56%$2.48$2.2525,050 shs$20.67 million04/04/2024$2.25$2.25$2.29$2.099,192 shs$19.21 million04/03/2024$2.34$2.25-3.85%$2.36$2.2511,176 shs$19.22 million04/02/2024$2.36$2.34-0.64%$2.37$2.266,816 shs$19.98 million04/01/2024$2.24$2.36+5.13%$2.52$2.2630,486 shs$20.11 million03/29/2024$2.24$2.24$2.42$2.0357,043 shs$19.13 million03/28/2024$2.49$2.24-10.04%$2.42$2.0355,513 shs$19.13 million03/27/2024$2.77$2.49-10.11%$2.80$2.4056,682 shs$21.27 million03/26/2024$2.44$2.77+13.52%$2.93$2.47133,584 shs$23.66 million03/25/2024$2.32$2.44+5.17%$2.61$2.1579,484 shs$20.84 million03/22/2024$2.27$2.32+2.20%$2.34$2.2014,167 shs$19.81 million03/21/2024$2.32$2.27-2.16%$2.40$2.2120,258 shs$19.39 million03/20/2024$2.05$2.32+13.17%$2.44$2.12113,850 shs$19.81 million03/19/2024$1.93$2.05+6.22%$2.09$1.967,259 shs$17.51 millionAmerica’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now.03/18/2024$1.87$1.93+3.21%$2.10$1.9329,477 shs$16.48 million03/15/2024$1.91$1.87-2.09%$2.01$1.8729,747 shs$15.71 million03/14/2024$2.00$1.91-4.50%$2.03$1.916,541 shs$16.05 million03/13/2024$2.07$2.00-3.38%$2.06$1.9427,683 shs$16.80 million03/12/2024$2.02$2.07+2.48%$2.11$1.9628,948 shs$17.39 million03/11/2024$2.15$2.02-6.05%$2.14$1.9926,798 shs$16.97 million03/08/2024$1.89$2.16+14.29%$2.17$1.8641,797 shs$18.14 million03/07/2024$1.95$1.89-3.08%$1.90$1.8115,795 shs$15.88 million03/06/2024$2.19$1.95-10.96%$2.16$1.67237,787 shs$16.38 million03/05/2024$2.36$2.19-7.20%$2.55$2.06171,085 shs$18.40 million03/04/2024$2.09$2.36+12.92%$2.60$2.123.37 million shs$19.82 million03/01/2024$2.20$2.09-5.00%$2.20$2.0025,933 shs$17.56 million02/29/2024$1.98$2.20+11.11%$2.57$2.07196,938 shs$18.48 million02/28/2024$1.94$1.98+2.06%$1.98$1.9418,370 shs$16.63 million02/27/2024$1.92$1.94+1.04%$1.94$1.8112,867 shs$16.30 million02/26/2024$1.82$1.92+5.49%$1.97$1.7227,703 shs$16.13 million02/23/2024$1.91$1.82-4.71%$1.93$1.7820,889 shs$15.29 million02/22/2024$1.70$1.91+12.35%$1.98$1.7285,604 shs$16.04 million02/21/2024$1.72$1.70-1.16%$1.77$1.616,368 shs$14.28 million02/20/2024$1.63$1.72+5.52%$1.75$1.627,429 shs$14.45 million02/19/2024$1.63$1.63$1.76$1.6013,600 shs$13.69 million02/16/2024$1.74$1.63-6.32%$1.76$1.6013,624 shs$13.69 million02/15/2024$1.68$1.74+3.57%$1.76$1.698,976 shs$14.62 million02/14/2024$1.64$1.68+2.44%$1.68$1.612,294 shs$14.11 million02/13/2024$1.69$1.64-2.96%$1.76$1.5611,429 shs$13.78 million Related Companies: VINC Stock Price Chart NERV Stock Price Chart NRSN Stock Price Chart VBIV Stock Price Chart AYTU Stock Price Chart TLPH Stock Price Chart ORGS Stock Price Chart TRAW Stock Price Chart VAXX Stock Price Chart APM Stock Price Chart Receive INDP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INDP) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsElon’s New Device is About to Shock the WorldInvestorPlaceTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.